INTRODUCTION
Cryptosporidium spp. are intestinal protozoan parasites that infect a wide range of hosts including ruminants and humans [Reference Fayer, Fayer and Xiao1]. The parasites are ubiquitous and several species cause acute gastroenteritis in humans. Cryptosporidiosis is usually a self-limiting disease, but can be life threatening in immunocompromised and malnourished individuals. So far, 25 species, as well as a number of potentially new variants of Cryptosporidium have been described [Reference Fayer, Santin and Macarisin2–Reference Elwin7]. Most human cases are caused by Cryptosporidium parvum, which also infects some other mammals, notably cattle, and Cryptosporidium hominis, which primarily infects humans. Infection is acquired by ingestion of oocysts, which are shed in the stool of infected animals or humans.
Cryptosporidium oocysts are resistant to chlorine at concentrations used for water treatment, and waterborne transmission has been frequently reported. Outbreaks have been associated both with drinking water and swimming pools [Reference Insulander8–Reference MacKenzie10]. The largest known outbreak occurred in Milwaukee in 1993 and affected more than 400 000 persons [Reference MacKenzie10]. The largest known Swedish outbreak occurred during winter 2010–2011 and affected about 20 000 individuals [11]. In recent years, powerful molecular tools have been developed to subtype C. hominis and C. parvum [Reference Xiao, Ryan, Fayer and Xiao12]. The subtypes of the latter species differ in host specificity, some are zoonotic, some anthroponotic, and some bovine [Reference Mallon13].
Although cryptosporidiosis is a notifiable disease in Sweden, only 100–400 cases are reported annually. The true incidence is likely to be higher since most laboratories do not test for Cryptosporidium unless requested by the clinician. The aim of the current study was to describe epidemiological features and clinical symptoms in patients with cryptosporidiosis in Stockholm County.
METHODS
Patients
From 1 April 2006 to 31 November 2008, all patients with cryptosporidiosis, living in Stockholm County, Sweden, were included in the study through mandatory notifications of confirmed cases by the parasitological laboratory. A questionnaire was sent out enquiring about travel abroad during the 2 weeks before disease onset, symptoms, and symptoms in household members. A follow-up questionnaire 6–36 months after disease onset provided information about treatment, persisting symptoms and complications. A second follow-up questionnaire was completed after a further 9 months by those individuals who reported persisting symptoms or complications at the first follow-up. The study was approved by the ethics committee of Karolinska Institutet, Stockholm, Sweden.
Microbiological investigations
Three parasitological laboratories in Stockholm participated in the study. Submitted stool specimens were screened for the presence of parasites including Cryptosporidium by light microscopy on wet smears after formol-ethyl acetate concentration. Correct identification of Cryptosporidium oocysts was confirmed by modified Ziehl–Neelsen staining. This staining was also performed on all specimens where Cryptosporidium was specifically requested. In all, 271 specimens contained confirmed Cryptosporidium oocysts. One hundred and ninety five (72%) stool specimens, most analysed at the Karolinska University Laboratory, Stockholm, were forwarded to the Swedish Institute for Communicable Disease Control (SMI), Solna for molecular analyses. The remaining 76 (28%) samples were initially preserved in sodium acetate-acetic acid-formalin fixative and therefore not suitable for molecular analyses. Stool specimens were also cultured on selective media for bacterial enteropathogens. Detected Salmonella spp., Shigella spp., Yersinia spp., Aeromonas spp., Plesiomonas spp., and Campylobacter spp. were identified by use of routine diagnostic methods (details can be found in the Swedish Institute for Communicable Disease Control database [14]). Stool specimens from patients with bloody diarrhoea were additionally analysed for enterohaemorrhagic Escherichia coli by detection of the verotoxin 1 and/or 2 genes by polymerase chain reaction (PCR), and serological typing, as described previously [Reference Svenungsson15].
Molecular analysis
DNA was extracted directly from stool specimens using the QIAamp DNA mini kit (Qiagen, Germany) according to the manufacturer's recommendations. Disruption of oocysts was performed before extraction using a Mini-BeadBeater (Biospec Products Inc., USA) [Reference Lebbad16]. On a limited number of samples where no amplicons were obtained, a new extraction was performed on oocysts isolated by a sucrose gradient [Reference Lebbad16].
The Cryptosporidium oocyst wall protein (COWP) and the 18S rRNA genes were examined on all isolates using PCR and subsequent restriction fragment-length polymorphism (RFLP) [Reference Xiao17, Reference Spano18]. Sequencing in both directions using standard techniques was performed on a limited number of isolates, (i) to confirm species, (ii) in case of ambiguous or unusual RFLP profiles, (iii) when amplicons were obtained at one locus only.
For subtype analysis of isolates identified as C. hominis or C. parvum, a nested PCR protocol was used to amplify the 60 kDa glycoprotein (Gp60) gene as described by Chalmers et al. [Reference Chalmers19]. All sequences obtained were compared with published sequences in the GenBank database using BLAST [Basic Local Alignment Search Tool, NCBI (http://www.ncbi.nlm.nih.gov/BLAST)]. Representative nucleotide sequences have been deposited in GenBank under accession numbers JN867334–JN867336.
Statistical methods
Fisher's exact test and χ2 test were used to evaluate differences between characteristics in patients infected with different Cryptosporidium spp. Mann–Whitney U test was used to compare ages of patients infected with different Cryptosporidium spp. JMP software (SAS Institute, USA.) was used for all statistical calculations.
RESULTS
Microbiological and genotyping results
Cultures for bacterial enteropathogens, performed on faecal samples of 232/271 patients, revealed 13 (6%) individuals with bacterial infections including Campylobacter (n=6), Salmonella (n=4), Shigella (n=1), enterohaemorrhagic E. coli (n=1), and mixed Salmonella and Shigella infection (n=1). Parasitological examination of all samples detected, in addition to Cryptosporidium spp., the following parasites: Giardia intestinalis (n=3), Blastocystis hominis (n=1), and non-pathogenic amoebas (n=6).
Species determination was successfully accomplished in 194/195 analysed isolates (Table 1). RFLP analysis of amplified products of the COWP and 18S rRNA genes revealed identical results in 185 isolates: C. hominis (n=64), C. parvum (n=110) and C. meleagridis (n=11). Thirteen randomly selected isolates were sequenced at the 18S rRNA locus, all confirming the initial results. One isolate demonstrated a C. hominis pattern in the COWP–RFLP but a mixed C. hominis/C. parvum pattern in the 18S rRNA–RFLP. Sequencing confirmed a mixed infection. Two isolates were only amplified at the COWP locus, where RFLP and subsequent sequencing identified one as C. hominis and one as C. parvum. In addition, six isolates were either negative, or showed inconclusive RFLP patterns, at the COWP locus. At the 18S rRNA locus two of these isolates were identified as C. felis (RFLP and sequencing), two as Cryptosporidium chipmunk genotype 1 (sequencing), and two had 100% homology with isolate W14532 (GenBank accession no. HM485434), a recently described species designated C. viatorum [Reference Elwin7]. One isolate remained negative despite repeated PCR trials (Table 1).
Table 1. Cryptosporidium spp. distribution* and probable area of origin of the disease in 271 patients with cryptosporidiosis, as related to species
* Cryptosporidium isolates from 195/271 patients were available for molecular analysis.
† Includes 76 cases that were not available for species determination and one isolate that remained negative despite repeated PCR trials.
Sixty-three of 65 C. hominis isolates were successfully subtyped at the Gp60 locus. Isolates belonged to allele families Ia (n=5), Ib (n=44), Id (n=10), Ie (n=1), and If (n=3) (Table 2). IbA10G2 was the dominating subtype with 37 cases, and this was the only C. hominis subtype identified in domestic cases. One patient who had travelled to China was infected with subtype IbA19G2. A IfA12G2 isolate originating from South Africa was identical to a C. hominis sequence from a baboon in Kenya (GenBank accession no. JF681172).
Table 2. Subtypes of C. hominis and C. parvum from 171 cases of human cryptosporidiosis in Stockholm County, Sweden
Of 111 C. parvum isolates, 107 were successfully subtyped and belonged to allele families IIa (n=69), IIc (n=11), IId (n=24), IIe (n=1) and novel allele family IIo (n=2) (Table 2). All domestic cases were from allele families IIa and IId, with subtypes IIaA16G1R1 and IIaA17G1R1 dominating due to their involvement in confirmed outbreaks. The 11 IIc isolates were of two different subtypes, IIcA5G3a (n=6) and novel subtype IIcA5G3k (n=5, all from Kerala, India). The novel allele family was matched to IIdA16G1 in the BLAST search but had 69 mutations in the 647-bp post-repetitive sequence compared to the best matching sequence (Gen Bank accession no. FJ917372), including substitutions as well as insertions and deletions. Gp60 analysis of the case with mixed C. hominis/C. parvum infection identified subtypes IaA23R3 and IIcA5G3a.
Patient characteristics
Patients were either sporadic cases (n=181), belonged to outbreaks (n=60) or were identified by contact tracing, i.e. follow-up of household contacts to Cryptosporidium index cases (n=30). There were 126 male and 145 female patients. The age distribution of the patients was bimodal with peaks in children aged <9 years and adults aged 30–39 years (Fig. 1). No differences in age distribution between males and females were found. Median age in patients with C. hominis (11 years, range 0–63 years) was lower compared to all cases (32 years, range 1–73 years), C. parvum (34 years, range 1–72 years) cases, and C. meleagridis (33 years, range 1–73 years) cases (P<0·0001). The monthly distribution of cases is illustrated in Figure 2. Most cases occurred during August–October, when also four of the five outbreaks were identified, one in 2007 and three in 2008. If outbreaks were excluded, the seasonal pattern was less evident (Fig. 2).
Fig. 1. Age distribution of Cryptosporidium parvum and Cryptosporidium hominis cases, diagnosed in Stockholm County during the study period, April 2006 to November 2008.
Fig. 2. Monthly distribution of Cryptosporidium parvum and Cryptosporidium hominis cases diagnosed in Stockholm County during the study period, April 2006 to November 2008. The five outbreaks are described in the text.
Travel history
Of the 271 patients, 157 (58%) had travelled outside Sweden during the previous 2 weeks (Table 1). Half of the C. parvum cases, 57/111 (51%), were probably infected in Sweden as opposed to C. hominis cases, that were most likely infected abroad, 48/65 (74%) (P=0·002). Of 17 C. hominis cases infected in Sweden, 14 were most likely secondary to index cases infected abroad. Only seven patients had contacts with farms and farm animals, all of them were infected with C. parvum belonging to zoonotic allele families IIa and IId. The patient with both C. parvum and C. hominis was a household contact of a patient who had visited Eritrea and from whom only C. hominis could be isolated. All but one of 11 C. meleagridis cases were infected in Asia. One of the two patients with C. felis was infected during a vacation in India. The other patient had contact with a kitten with diarrhoea 3 weeks before disease onset.
Two unrelated patients, infected in Sweden, carried Cryptosporidium chipmunk genotype 1. Two other patients, who had travelled to Kenya and Guatemala, respectively, were infected with C. viatorum [Reference Elwin7]. These four cases will be described in more detail in a forthcoming publication.
Clinical manifestations
Clinical manifestations in relation to species/genotypes are shown in Table 3. Frequent diarrhoea that lasted for >10 days was more common in patients with C. parvum than in patients with C. hominis (P=0·003) or C. meleagridis (P=0·005). Vomiting was more common in C. meleagridis patients compared to C. parvum patients (P=0·006) or C. hominis patients (P=0·04). Fever was reported by 50% of patients, but there were no significant differences between species. Forty (15%) patients were hospitalized. There was no correlation between infection with a specific species and hospitalization. Four patients were immunocompromised, three of whom were HIV-positive. Cryptosporidium isolates from these patients were not available for genotyping.
Table 3. Reported symptoms in 251 cryptosporidiosis patients that answered the specific questions of the first questionnaire*. Patients with mixed infections with other enteropathogens are excluded. Data are findings/no. of patients who answered the specific questions (%)
* Response rates for the different questions in the questionnaire varied from 86% to 100%.
† Includes 71 cases where species was not determined and five cases with species/genotypes other than C. parvum, C. hominis, or C. meleagridis.
‡ No significant differences.
§ Significant difference between C. parvum and C. meleagridis (P=0·03).
¶ Significant difference between C. parvum and C. meleagridis (P=0·006), and C. hominis and C. meleagridis (P=0·04).
∥ Significant difference between C. parvum and C. hominis (P=0·02).
# Significant difference between C. parvum and C. hominis (P=0·04), and C. parvum and C. meleagridis (P=0·02).
$ Significant difference between C. parvum and C. hominis (P=0·003), and C. parvum and C. meleagridis (P=0·005).
Persisting symptoms at different time intervals after disease onset, based on the combined results from the two follow-up questionnaires, are shown in Table 4. The first follow-up questionnaire was completed 6–36 months after disease onset by 196/271 patients (72%). The second follow-up questionnaire was completed after another 9 months by 22/32 patients (69%) who reported persisting symptoms at the first follow-up. The response rates for the various questions at follow-up were 69% and 75%, respectively. After 25–36 months, intermittent diarrhoea and abdominal pain were still reported by 15% and 9% of the patients, respectively. There was no difference in frequency of persisting symptoms between patients infected with C. parvum or C. hominis (data not shown).
Table 4. Persisting symptoms in 196 cryptosporidiosis patients that answered the follow-up questionnaires. Patients with mixed infections with other enteropathogens were excluded. Data are findings/no. of patients who answered the specific questions after different time intervals
* Time after disease onset.
Outbreaks and family clusters
During the study period, five outbreaks and 16 family clusters of cryptosporidiosis, involving 60 and 47 laboratory-confirmed cases, respectively, were identified.
Outbreak 1
At a conference, 20/50 participants became ill with watery diarrhoea. Nine of 17 individuals who supplied faecal specimens were positive for Cryptosporidium by microscopy. All nine contained C. parvum. Eight samples were successfully subtyped and contained subtype IIaA21R1. Epidemiological data suggested an association with in-house water consumption [Reference Hajdu20].
Outbreak 2
One adult and 8/14 children with diarrhoea at a day-care centre were positive for Cryptosporidium. Two samples were available for molecular analysis and C. parvum subtype IIdA22G1 was identified. The infection was probably caught from a diarrhoeal index child by swimming together in a pool [Reference Persson, Svenungsson and de Jong21].
Outbreak 3
Twenty-one cases of diarrhoea occurred among guests and staff at a wedding reception. Sixteen of the cases were positive for Cryptosporidium and all 13 isolates that were available for molecular analysis contained C. parvum subtype IIaA17G1R1. The suspected vehicle of infection was chopped fresh parsley [Reference Insulander, de Jong and Svenungsson22].
Outbreak 4
At a day-care centre, seven children and one household contact were infected with Cryptosporidium. Six samples were used for molecular analysis, and C. hominis subtype IbA10G2 was identified. The infection was probably acquired from the index child who had fallen ill with diarrhoea after a trip abroad.
Outbreak 5
An increase of sporadic domestic cases of cryptosporidiosis was observed in Stockholm County in autumn 2008. In total, 18 cases were notified. The suspected source of infection, based on a case-control study, was arugula salad. Molecular analysis of 15 samples identified four subtypes of C. parvum in this outbreak, IIaA16G1R1 (n=10), IIaA15G2R1 (n=1), IIdA22G1 (n=3), and IId19G1 (n=1).
Family clusters
Cryptosporidium isolates from 39/47 cases that belonged to 16 different family clusters were analysed. In the 13 clusters where more than one sample was subtyped, isolates from patients within each cluster were of identical subtypes (Table 5). The transmission route was most likely from child to parent in six of the family clusters, from parent to child in one cluster, and between siblings in one cluster. In the remaining family clusters, the source of infection was unknown.
Table 5. Subtypes of C. parvum and C. hominis from 39 of 47 individuals belonging to 16 different family clusters
* One of the cases was also infected with C. parvum.
† One Cryptosporidium isolate could not be subtyped.
DISCUSSION
The present study is the first to genetically characterize human Cryptosporidium isolates from Swedish patients and to compare the associations of species with clinical manifestations.
The predominance of C. parvum is in contrast to findings from many other industrial and developing countries, where C. hominis often dominates [Reference Brook23–Reference Ng, MacKenzie and Ryan27]. In Europe, the two species are rather evenly distributed, with C. parvum being more prevalent in some reports [Reference Zintl28] and C. hominis in others [Reference Chalmers24, Reference Chalmers29, Reference Wielinga30].
A primarily zoonotic transmission route of domestic C. parvum infection was indicated, because all such isolates belonged to zoonotic allele families IIa and IId, whereas infections with subtypes from anthroponotic allele families IIc and IIe were all apparently acquired abroad. However, since the present study was performed in an urban area, where contact with farm animals is minimal, other transmission routes like consumption of contaminated food or water might possibly have been more important. It is also possible that some of the subtypes identified as zoonotic circulate within the human population without intermingling with animal hosts, as has been shown in Scotland [Reference Mallon13].
Epidemiological characteristics such as source of infection and transmission routes may explain differences in geographical distribution between C. hominis and C. parvum. C. hominis is transmitted only between humans whereas C. parvum infections can result from either zoonotic or anthroponotic transmission. Infections with C. parvum have, accordingly, been linked to contact with farms and farm animals, and infections with C. hominis with travel abroad and contact with other individuals with diarrhoea [Reference Chalmers24, Reference Chalmers29, 31]. Both species have been associated with drinking-water and swimming-pool outbreaks [Reference Insulander8, Reference MacKenzie10]. Consequently, data from different reports are most likely influenced by the characteristics of the population studied, such as whether people included were living in urban or rural areas, socioeconomic, seasonal and demographic factors and the occurrence of outbreaks during the study period. The predominance of C. hominis in developing countries, suggesting primarily anthroponotic transmission, is probably associated with hygiene practices and contaminated drinking water.
Cryptosporidium spp. other than C. parvum and C. hominis were identified in 8·7% of the cases, the most common being C. meleagridis (6%). This figure is high compared to studies from other developed countries, where C. meleagridis usually accounts for only about 1% of cases [31, Reference Leoni32]. Most of our patients were infected in Thailand (data not shown), a very popular tourist destination for Swedes, and a country where C. meleagridis seems to be more prevalent than C. parvum, at least in immunocompromised patients [Reference Saksirisampant33–Reference Tiangtip and Jongwutiwes35]. We also report a recently described species, C. viatorum, identified in two patients. This species has been identified in ten persons that had travelled to India, Nepal, Pakistan or Bangladesh [Reference Elwin7]. Interestingly, our patients had travelled to South America and Africa and had no connection with each other. One patient had a mixed C. hominis and C. parvum infection, a proportion comparable with data from other reports [Reference Chalmers24, Reference Molloy26, Reference Leoni32, Reference McLauchlin36].
The median age of patients differs from reports from both developed and developing countries, where children aged <10 years usually predominate [Reference Semenza and Nichols9, Reference Chalmers24, Reference Chalmers29–31]. High drinking-water quality and sanitary conditions in Sweden may prevent infections in children. Moreover, three of the five outbreaks involved mainly adults.
The bimodal age distribution is in agreement with studies from France [31], The Netherlands [Reference Wielinga30], and the USA [Reference Yoder37]. Patients infected with C. hominis were significantly younger compared to the whole group of patients as well as those infected with C. parvum. Many were children aged <10 years. This difference has also been found in other European countries [Reference Wielinga30, Reference Lake38] and may reflect child behaviours that favour infections with C. hominis, like close person-to-person contacts and frequent swimming in pools. In contrast to C. parvum cases, the age distribution of C. hominis cases was bimodal. This may reflect transmission between parents and their children.
The predominance of cases in late summer and autumn has also been noted in reports from the USA and other European countries [Reference Semenza and Nichols9, Reference Wielinga30, 31, Reference McLauchlin36–Reference Lake38], except for the UK and Ireland, where a spring peak, mainly due to C. parvum infections, was noted [Reference Zintl28]. Four of the five outbreaks in the present study occurred in late summer and autumn, which in part may explain the increased number of cases during this season. Seasonal behaviours, e.g. increased outdoor activities, international travel, and swimming pool use in summer and autumn may be another explanation.
Almost 60% of cases reported travel abroad in the 2 weeks prior to disease onset. That travel is a risk factor for cryptosporidiosis among Swedes may, however, be biased by the fact that people are more prone to seek healthcare for diarrhoea acquired abroad and physicians more likely order Cryptosporidium investigation in cases with travellers' diarrhoea than in indigenous cases. There was, however, a difference between C. parvum cases, where 51% were infected in Sweden and C. hominis cases, where 74% acquired their infection abroad. A predominance of C. hominis in travel-associated cases has also been observed in previous studies from developed countries [Reference Chalmers24, Reference Chalmers29, Reference McLauchlin36] and most likely reflects the local incidence of different Cryptosporidium spp. in different countries, as well as differences in behaviour and exposure during travel abroad. Moreover, the majority of indigenous C. hominis cases in this study probably acquired their infection by person-to-person transmission from an index case infected abroad.
Main clinical symptoms were frequent diarrhoea and abdominal pain, as described previously [Reference Insulander8, Reference Chalmers24, Reference Gatei25]. More patients were hospitalized and in need of intravenous rehydration compared to 8·9% in a study by Chalmers et al. [Reference Chalmers24]. Moreover, up to 70% of the patients had symptoms for >10 days, and 25–36 months after disease onset 15% of patients still reported intermittent diarrhoea and 8% complained of musculoskeletal symptoms. A few reports have shown clinical manifestation differences between C. hominis and C. parvum [Reference Ajjampur39–Reference Cama41] suggesting a higher pathogenicity of C. hominis, especially in HIV-infected persons, and also differences between subtype families [Reference Ajjampur39, Reference Cama40, Reference Iqbal, Khalid and Hira42]. There were, however, only slight differences in the intensity of clinical symptoms by species in patients in the present study, in agreement with reports from the UK and France [Reference Chalmers24, 31]. The duration of diarrhoea was longer in patients infected with C. parvum compared to those infected with C. hominis. Persistent symptoms after cryptosporidiosis have been described by others, but especially after infection with C. hominis in children [Reference Gatei25, Reference Ajjampur39, Reference Cama40]. Only four patients in the present study were immunocompromised, which emphasizes that immunocompetent individuals are also susceptible to many Cryptosporidium spp. and genotypes.
Subtyping is a vital tool in epidemiological investigations due to the wide range of intra-species diversity. For example, multilocus typing (MLT) of three microsatellites of isolates from a presumed single C. parvum outbreak in Sweden, involving two swimming pools, identified different MLTs suggesting two parallel outbreaks [Reference Mattsson43]. Some of these isolates were later typed at the Gp60 locus, identifying subtypes IIaA16R1 and IIcA5G3a, confirming two separate infection sources (M. Lebbad, unpublished data). In four of the outbreaks as well as in suspected family clusters described in this study, a single subtype was identified, providing evidence of a common infection source. In the fifth outbreak, involving arugula salad as the suspected source, we identified four subtypes from allele families IIa and IId. These allele families are recognized as zoonotic, and contamination due to fertilization with animal faeces during cultivation cannot be ruled out. Subtype clonality of C. parvum has been identified in some cattle herds, whereas some herds seem to harbour multiple subtypes [Reference Brook23, Reference Trotz-Williams44]. Thus, it is difficult to determine whether one or several infection sources were involved in this particular outbreak.
C. hominis subtype IbA10G2 was predominant, and this subtype has also been identified as the most common C. hominis subtype worldwide [Reference Zintl28, Reference Wielinga30, Reference Jex45]. Even if ten outbreak-related cases were excluded, 43% of C. hominis cases were due to this subtype. In agreement with findings from the UK, having a non-IbA10G2 subtype was associated with recent travel outside Europe [Reference Chalmers46]. The IbA19G2 subtype, identified in one visitor to China, has so far only been identified in China [Reference Feng47, Reference Wang48], and could thus currently be geographically isolated.
Domestic C. parvum cases in this study all belonged to zoonotic allele families IIa and IId. Except for dairy cattle, little is known about Cryptosporidium prevalence, species and subtype distribution and zoonotic potential in Swedish animals. In a previous study we identified C. parvum in only 20% of 115 analysed Cryptosporidium-positive calf samples from calves aged 1–62 days [Reference Silverlås49], indicating that the overall zoonotic potential of Swedish dairy cattle is low. However, subtype IIaA16G1R1, frequently identified in domestic cases in this study, was common in calves whereas IIaA17G1R1, which was involved in outbreak 3, was only identified in one calf [Reference Silverlås49]. We also identified three novel subtypes (IIaA21G1R1, IIdA16G1, IIdA23G1) and two subtypes with post-repetitive variations (IIdA20G1e, IIdA22G1c) in calves [Reference Silverlås49]. Interestingly, IIdA22G1c was identified in seven human domestic cases and in two travel cases in the present study. IIdA16G1 and IIdA20G1e were identified in one travel case each, whereas IIaA21G1R1 and IIdA23G1 were not identified. This further emphasizes that calves should be taken into consideration as a source of infection. Subtype IIaA15G2R1, which has been highly prevalent in both humans and cattle in previous reports [Reference Wielinga30, Reference Jex45] was identified in 14 cases, most of them apparently infected abroad. We have not found this subtype in Swedish dairy cattle [Reference Silverlås49]. The widespread occurrence of this subtype in humans might suggest that this subtype also circulates in human populations without zoonotic transmission.
Our study has some limitations. First, only patients in Stockholm County, representing about 20% of the Swedish population, were included and data are thus not representative for the whole country. Second, Cryptosporidium isolates from only about 70% of cases were available for molecular analysis.
In conclusion, the majority of cryptosporidiosis patients in this study were infected by C. parvum followed by C. hominis and C. meleagridis. Clinical manifestations differed by species. A high diversity of Cryptosporidium spp. and subtypes was identified and molecular characterization of isolates was crucial for epidemiological investigations and contact tracing. There is need for increased awareness of cryptosporidiosis among physicians and laboratory personnel to correctly assess the burden of cryptosporidiosis. Stool specimens from individuals with diarrhoea should routinely be tested for Cryptosporidium and notification of confirmed cases to public health agencies should be mandatory in order to improve the prevention of cryptosporidiosis and the understanding of its epidemiology.
ACKNOWLEDGEMENTS
We thank Katarina Näslund for skilful work in the laboratory and Dr Lihua Xiao for valuable advice on sequence interpretation.
DECLARATION OF INTEREST
None.
